医薬品用賦形剤市場:2029年までの世界市場

Excipients in Pharmaceuticals: Global Markets to 2029

医薬品用賦形剤市場:2029年までの世界市場

商品番号 : SMB-67025

出版社BCC Research
出版年月2024年9月
ページ数105
価格タイプシングルユーザライセンス
価格USD 5,500
種別英文調査報告書

Report Highlights

The global market for pharmaceutical excipients was valued at $9.2 billion in 2023. It is expected to grow from $9.7 billion in 2024 to $12.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.1% from 2024 to 2029.

医薬品用賦形剤の世界市場は、2023 年に 92 億ドルと評価されています。2024 年から 2029 年までの年間平均成長率 (CAGR) は 5.1% で、2024 年の 97 億ドルから 2029 年末までに 124 億ドルに成長すると予想されています。

Summary:

This report provides a comprehensive summary of pharmaceutical excipients, along with a discussion of the competitive landscape and profiles of key market players that highlight revenues, product portfolios, and recent activities. The report analyzes trends and dynamics, including drivers, limitations, challenges and opportunities. This research study discusses historical, current and potential market size. The report will enable market players and new entrants to make informed decisions about the production and licensing of goods and services. Organizations, distributors and exporters will find useful information about market developments and trends. The report segments the market by three product types: organic, inorganic or water that meets the standards of the U.S. Pharmacopeia (USP). Regional and country-level market analysis is provided for all the major segments. The market excludes the excipients used in the cosmetics, food and beverage, and chemical industries.

Report Scope

This report provides a comprehensive summary of pharmaceutical excipients, along with a discussion of the competitive landscape and profiles of key market players that highlight revenues, product portfolios, and recent activities. The report analyzes trends and dynamics, including drivers, limitations, challenges and opportunities. This research study discusses historical, current and potential market size. The report will enable market players and new entrants to make informed decisions about the production and licensing of goods and services. Organizations, distributors and exporters will find useful information about market developments and trends. The report segments the market by three product types: organic, inorganic or water that meets the standards of the U.S. Pharmacopeia (USP). Regional and country-level market analysis is provided for all the major segments. The market excludes the excipients used in the cosmetics, food and beverage, and chemical industries.

The market is divided into segments as follows:

By excipient material type:

– Organic.

– Inorganic.

– USP water.

By organic type:

– Carbohydrates.

– Petrochemicals.

– Oleochemicals.

– Proteins.

– Other organic excipients.

By inorganic type:

– Calcium salts.

– Halites.

– Metal oxides.

– Silicates.

– Other inorganic excipients.

By dosage form:

– Solid dosage form.

– Liquid dosage form.

– Semisolid dosage form.

– Other dosage forms.

By administration route:

-Oral.

– Injectable.

– Topical.

– Advanced drug delivery.

By end user:

– Pharmaceutical companies.

– Contract formulators.

– Research institutes.

– Other end users.

For each area, for the base year of 2023, BCC Research identified the current products in the market as well as market drivers; measured the current market size; quantified current company market shares; and made forecasts for 2029.

Report Synopsis

Report MetricsDetails
Base year considered2023
Forecast period considered2024-2029
Base year market size$9.2 Billion
Market size forecast$12.4 Billion
Growth rateCAGR of 5.1% from 2024 to 2029
Units considered$ Millions
Segments coveredBy Material Type, Dosage Form, Route of Administration, End User, and Region
Regions coveredNorth America, Europe, Asia-Pacific, Latin America, and Rest of the World
Key Market Drivers
  • Increasing pharmaceutical and biopharmaceutical consumption
  • Growing demand for functional and novel excipients
  • Instant sourcing of excipients
Companies studied
ADMASAHI KASEI CORP.
ASHLANDBASF SE
CRODA INTERNATIONAL PLCEVONIK INDUSTRIES AG
INGREDIONKERRY GROUP PLC
ROQUETTE FRERES

Report Includes

– 73 data tables and 33 additional tables

– An overview of the global market for excipients in pharmaceuticals industry

– Analysis of global market trends, featuring historical revenue data from 2021 to 2023, estimated figures for 2024, and projected CAGRs through 2029

– Evaluation of the current market’s size and revenue growth prospects, along with a market share analysis by material, product type, dosage form, route of administration, end user and region

– A look at the innovations, technological advances, clinical trials, and recent product launches

– Analysis of the industry’s regulatory framework and policies

– A discussion of ESG challenges and ESG practices in the industry

– An analysis of the key companies’ market shares, proprietary technologies, strategic alliances and patents

– Profiles of the leading players, including ADM, BASF SE, Roquette Frères, Ashland Global, and Croda International Plc.

Table of Contents

Chapter 1 Executive Summary

Market Outlook

Scope of Report

Market Summary

Chapter 2 Market Overview

Role of Excipients in Pharmaceuticals

Functions of Excipients

Chapter 3 Market Dynamics

Market Dynamics Snapshot

Market Drivers

Increasing Pharmaceutical and Biopharmaceutical Consumption

Increasing Demand for Functional Excipients

Increasing Demand for Novel Excipients

Instant Sourcing of Excipients

Market Restraints

High Development Costs

Lack of Independent Regulatory Body for Novel Excipients

Stringent Pharmaceutical Regulations

Market Opportunities

Growing Demand for Biologics, Biosimilars and Specialty Drugs

Market Challenges

Supply Chain Disruptions

Chapter 4 Emerging Technologies and Developments

Overview

3D Printing in Drug Formulations

AI in Excipient Selection

Novel Excipients

Clinical Trials

Selected Trials

Chapter 5 Global Market for Pharmaceutical Excipients

Segmentation Breakdown

Market Breakdown by Material Type

Organic Excipients Market, by Type

Market for Inorganic Excipients, by Type

Market for USP Water, by Type

Market Breakdown by Dosage Form

Market Breakdown by Route of Administration

Market Breakdown by End User

Geographic Breakdown

Market Breakdown by Region

North America

Europe

Asia-Pacific

Latin America

Rest of the World

Market Breakdown by Product

Regional and Country-level Markets for Organic Excipients

Regional and Country-level Markets for Inorganic Excipients

Chapter 6 Competitive Intelligence

Industry Scenario

Company Shares

Competitive Landscape

Chapter 7 Sustainability in the Market for Pharmaceutical Excipients: An ESG Perspective

Introduction to ESG

Environmental Performance

Social Performance

Governance Performance

Concluding Remarks from BCC

Chapter 8 Appendix

Research Methodology

Abbreviations

References

Company Profiles

ADM

ASAHI KASEI CORP.

ASHLAND

BASF SE

CRODA INTERNATIONAL PLC

EVONIK INDUSTRIES AG

INGREDION

KERRY GROUP PLC

ROQUETTE FRERES

List Of Tables

Summary Table : Global Market for Pharmaceutical Excipients, by Material Type, Through 2029

Table 1 : Cases of Diabetes, by Country, 2021

Table 2 : People Living with HIV Globally, by Region, 2022

Table 3 : Global Incidence of All Cancers, by Region, 2022–2045

Table 4 : Clinical Trials of Pharmaceutical Excipients

Table 5 : Global Market for Pharmaceutical Excipients, by Material Type, Through 2029

Table 6 : Global Market for Organic Excipients, by Product Type, Through 2029

Table 7 : Global Market for Carbohydrate Pharmaceutical Excipients, by Type, Through 2029

Table 8 : Global Market for Sugar Pharmaceutical Excipients, by Type, Through 2029

Table 9 : Global Market for Cellulose Pharmaceutical Excipients, by Type, Through 2029

Table 10 : Global Market for Starch Pharmaceutical Excipients, Through 2029

Table 11 : Global Market for Petrochemical-based Pharmaceutical Excipients, by Type, Through 2029

Table 12 : Global Market for Mineral Hydrocarbon-based Pharmaceutical Excipients, by Type, Through 2029

Table 13 : Global Market for Oleochemical-based Pharmaceutical Excipients, by Type, Through 2029

Table 14 : Global Market for Protein-based Pharmaceutical Excipients, by Type, Through 2029

Table 15 : Global Market for Other Organic Pharmaceutical Excipients, by Type, Through 2029

Table 16 : Global Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029

Table 17 : Global Market for USP Water, Through 2029

Table 18 : Global Market for Pharmaceutical Excipients, by Dosage Form, Through 2029

Table 19 : Global Market for Pharmaceutical Excipients, by Route of Administration, Through 2029

Table 20 : Global Market for Pharmaceutical Excipients, by End User, Through 2029

Table 21 : Global Market for Pharmaceutical Excipients, by Region, Through 2029

Table 22 : North American Market for Pharmaceutical Excipients, by Country, Through 2029

Table 23 : European Market for Pharmaceutical Excipients, by Country, Through 2029

Table 24 : Asia-Pacific Market for Pharmaceutical Excipients, by Country, Through 2029

Table 25 : Latin American Market for Pharmaceutical Excipients, by Country, Through 2029

Table 26 : RoW Market for Pharmaceutical Excipients, Through 2029

Table 27 : North American Market for Organic Pharmaceutical Excipients, by Type, Through 2029

Table 28 : U.S. Market for Organic Pharmaceutical Excipients, by Type, Through 2029

Table 29 : Canadian Market for Organic Pharmaceutical Excipients, by Type, Through 2029

Table 30 : Mexican Market for Organic Pharmaceutical Excipients, by Type, Through 2029

Table 31 : European Market for Organic Pharmaceutical Excipients, by Type, Through 2029

Table 32 : German Market for Organic Pharmaceutical Excipients, by Type, Through 2029

Table 33 : French Market for Organic Pharmaceutical Excipients, by Type, Through 2029

Table 34 : U.K. Market for Organic Pharmaceutical Excipients, by Type, Through 2029

Table 35 : Italian Market for Organic Pharmaceutical Excipients, by Type, Through 2029

Table 36 : Spanish Market for Organic Pharmaceutical Excipients, by Type, Through 2029

Table 37 : Rest of European Market for Organic Pharmaceutical Excipients, by Type, Through 2029

Table 38 : Asia-Pacific Market for Organic Pharmaceutical Excipients, by Type, Through 2029

Table 39 : Chinese Market for Organic Pharmaceutical Excipients, by Type, Through 2029

Table 40 : Japanese Market for Organic Pharmaceutical Excipients, by Type, Through 2029

Table 41 : Indian Market for Organic Pharmaceutical Excipients, by Type, Through 2029

Table 42 : Rest of Asia-Pacific Market for Organic Pharmaceutical Excipients, by Type, Through 2029

Table 43 : Latin American Market for Organic Pharmaceutical Excipients, by Type, Through 2029

Table 44 : Brazilian Market for Organic Pharmaceutical Excipients, by Type, Through 2029

Table 45 : Argentinian Market for Organic Pharmaceutical Excipients, by Type, Through 2029

Table 46 : Chilean Market for Organic Pharmaceutical Excipients, by Type, Through 2029

Table 47 : RoW Market for Organic Pharmaceutical Excipients, by Type, Through 2029

Table 48 : North American Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029

Table 49 : U.S. Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029

Table 50 : Canadian Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029

Table 51 : Mexican Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029

Table 52 : European Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029

Table 53 : German Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029

Table 54 : French Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029

Table 55 : U.K. Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029

Table 56 : Italian Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029

Table 57 : Spanish Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029

Table 58 : Rest of European Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029

Table 59 : Asia-Pacific Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029

Table 60 : Chinese Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029

Table 61 : Japanese Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029

Table 62 : Indian Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029

Table 63 : Rest of Asia-Pacific Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029

Table 64 : Latin American Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029

Table 65 : Brazilian Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029

Table 66 : Argentinian Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029

Table 67 : Chilean Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029

Table 68 : RoW Market for Inorganic Pharmaceutical Excipients, by Type, Through 2029

Table 69 : ESG: Environmental Performance

Table 70 : ESG: Social Performance

Table 71 : ESG: Governance Performance

Table 72 : Abbreviations Used in This Report

Table 73 : ADM: Company Snapshot

Table 74 : ADM: Financial Performance, 2022 and 2023

Table 75 : ADM: Product Portfolio

Table 76 : Asahi Kasei Corp.: Company Snapshot

Table 77 : Asahi Kasei Corp.: Financial Performance, 2022 and 2023

Table 78 : Asahi Kasei Corp.: Product Portfolio

Table 79 : Ashland: Company Snapshot

Table 80 : Ashland: Financial Performance, 2022 and 2023

Table 81 : Ashland: Product Portfolio

Table 82 : Ashland.: News/Key Developments, 2022

Table 83 : BASF SE: Company Snapshot

Table 84 : BASF SE: Financial Performance, 2022 and 2023

Table 85 : BASF SE: Product Portfolio

Table 86 : BASF SE: News/Key Developments, 2023

Table 87 : Croda International Plc: Company Snapshot

Table 88 : Croda International Plc: Financial Performance, 2022 and 2023

Table 89 : Croda International Plc: Product Portfolio

Table 90 : Croda International Plc: News/Key Developments, 2023

Table 91 : Evonik Industries AG: Company Snapshot

Table 92 : Evonik Industries AG: Financial Performance, 2022 and 2023

Table 93 : Evonik Industries AG: Product Portfolio

Table 94 : Evonik.: News/Key Developments, 2023

Table 95 : Ingredion: Company Snapshot

Table 96 : Ingredion: Financial Performance, FY 2022 and 2023

Table 97 : Ingredion: Product Portfolio

Table 98 : Ingredion: News/Key Developments, 2023

Table 99 : Kerry Group Plc: Company Snapshot

Table 100 : Kerry Group Plc: Financial Performance, 2022 and 2023

Table 101 : Kerry Group Plc: Product Portfolio

Table 102 : Kerry Group Plc: News/Key Developments, 2023

Table 103 : Roquette Frères: Company Snapshot

Table 104 : Roquette Frères: Product Portfolio

Table 105 : Roquette Frères: News/Key Developments, 2023 and 2024

List Of Figures

Summary Figure A : Global Market for Pharmaceutical Excipients, by Material Type, 2021-2029

Summary Figure B : Global Market Shares of Pharmaceutical Excipients, by Material Type, 2023

Figure 1 : Pharmaceutical Excipients: Market Dynamics

Figure 2 : Emerging Trends and Technologies in Pharmaceutical Excipients

Figure 3 : Global Market Shares of Pharmaceutical Excipients, by Company, 2023

Figure 4 : ESG Pillars

Figure 5 : Advantages of ESG for Pharmaceutical Excipient Companies

Figure 6 : ADM: Revenue Share, by Business Unit, 2023

Figure 7 : Asahi Kasei Corp.: Revenue Share, by Business Unit, 2023

Figure 8 : Asahi Kasei Corp.: Revenue Share, by Country/Region, 2023

Figure 9 : Ashland: Revenue Share, by Business Unit, 2023

Figure 10 : Ashland: Revenue Share, by Region, 2023

Figure 11 : BASF SE: Revenue Share, by Business Unit, 2023

Figure 12 : BASF SE: Revenue Share, by Region, 2023

Figure 13 : Croda International Plc: Revenue Share, by Business Unit, 2023

Figure 14 : Croda International Plc: Revenue Share, by Region, 2023

Figure 15 : Evonik Industries AG: Revenue Share, by Business Unit, 2023

Figure 16 : Evonik Industries AG: Revenue Share, by Region, 2023

Figure 17 : Ingredion: Revenue Shares, by Business Unit, 2023

Figure 18 : Ingredion: Revenue Share, by Region, 2023

Figure 19 : Kerry Group Plc: Revenue Share, by Business Unit, 2023

Figure 20 : Kerry Group Plc: Revenue Share, by Region, 2023